Find a Clinical Trial
Filter
PATH-2: PLS240
Hemodialysis access, Thyroid diseases
All genders
18-80
Recruiting now
Division of Nephrology
Collagen Urine Assay
Male
50-80
Recruiting now
Department of Urology
MLS-101-206
Chronic kidney disease
All genders
18-100
Recruiting now
Department of Medicine, Division of Nephrology
Takeda footprint
Neonatal care
All genders
0-1
Recruiting now
Department of Obstetrics + Gynecology
R3R
Chronic kidney disease
All genders
12+
Recruiting now
Department of Medicine, Division of Nephrology
Treatment Combination of Durvalumab, Tremelimumab and Enfortumab Vedotin or Durvalumab and Enfortumab Vedotin in Patients With Muscle Invasive Bladder Cancer Ineligible to Cisplatin or Who Refuse Cisplatin (VOLGA)
Bladder cancer
All genders
18+
Recruiting now
Department of Medicine, Cancer Center
LYS228 Pharmacokinetics for Complicated UTI
Urinary tract infections
All genders
18-85
Recruiting now
Department of Urology
TAP Block and minimally invasive hysterectomy for pain control
Uterine cancer
Female
18-80
Recruiting now
Department of Obstetrics + Gynecology
The Connection study
Premature babies, Premature birth
All genders
No minimum age
Recruiting now
Department of Obstetrics + Gynecology
Assist
Chronic kidney disease
All genders
18+
Recruiting now
Department of Medicine, Division of Nephrology